Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Vehicle-Controlled Study of the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

NCT05593432 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT05593432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05593432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Vehicle-Controlled Study of the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus
Lead sponsor
Incyte Corporation
Phase
Phase 2
Overall status
Completed
Start date
November 23, 2022
Completion date
February 26, 2024
Enrollment
64 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous lichen planus